logo
Plus   Neg
Share
Email

Seattle: TUKYSA Approved In Switzerland To Treat HER2-positive Breast Cancer

Seattle Genetics, Inc. (SGEN) announced the Swiss Agency for Therapeutic Products has granted approval for TUKYSA tablets in combination with trastuzumab and capecitabine, for the treatment of patients with metastatic HER2-positive breast cancer. The application for TUKYSA approval was reviewed by Swissmedic as part of Project Orbis, an initiative of the U.S. FDA Oncology Center of Excellence.

On April 17, the FDA approved TUKYSA in the U.S. under the FDA's Real-Time Oncology Review pilot program, and represented the first new drug approved under Project Orbis.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Twitter could face a fine of up to $250 million from the U.S. Federal Trade Commission regarding its use of phone numbers and email addresses to target advertisements. Lord & Taylor joined the growing list of U.S. retailers who filed for bankruptcy amid the coronavirus pandemic. Lord & Taylor, one of the oldest department store chains in the U.S., filed for bankruptcy protection in the Eastern Court of Virginia on Sunday. The company operated 38 stores that have remained temporarily closed since March this year due to the pandemic. Thomson International Inc. is recalling Red, Yellow, White, and Sweet Yellow Onions for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The onions are in distribution since May 1, 2020. They were sold to wholesalers, restaurants, and retail stores in all 50 U.S. states, the District of Columbia and Canada.
Follow RTT